Lilly Issues 2018 Guidance

Posted: Updated:
Lilly plans to present trial results at scientific meetings and publications this year and in 2016. Lilly plans to present trial results at scientific meetings and publications this year and in 2016.
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is expecting low-single-digit revenue growth next year. In its 2018 financial guidance, the drugmaker is projecting revenue to be between $23 billion and $23.5 billion, driven by recently-launched products including Trulicity, Taltz and Cyramza.

Lilly expects earnings per share for 2018 to be in the range of $4.24 to $4.34. The company is maintaining expectations for at least 5 percent average annual revenue growth from 2015 to 2020. Lilly is decreasing 2017 earnings per share guidance to $1.56 to $1.66, citing changes in estimates to restructuring and other special charges.

"Looking to the future," says Chief Executive Officer David Ricks, "the potential of our pipeline remains strong, including new medicines in development for the treatment of migraine, rheumatoid arthritis, pain, cancer and diabetes, as well as additional indications for many of our recently launched products."

Last month, Lilly said about 2,300 U.S. employees have taken voluntary early retirement as part of previously-announced global reduction plans. At the time, the company said those plans are "on track" to meet a 3,500-position target, in hopes of saving about $500 million in 2018.

  • Perspectives

    • 5 Things Consumers Should Know About Marketplace Health Insurance

      Open Enrollment is upon consumers again and there are likely questions on what they should do in terms of health care coverage for 2020. Options for coverage can be overwhelming, but consumers can choose a plan that fits them best through education on open enrollment, understanding what’s new in terms of health plans and learning of any changes going into 2020.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • An abandoned East Chicago neighborhood is fenced off for safety. (photo ctsy: The Times of Northwest Indiana)

      New Housing Coming to East Chicago

      The Indiana Housing & Community Development Authority has selected a Chicago nonprofit to participate in a new workforce housing program in East Chicago, according to our partners at The Times of Northwest Indiana. The nonprofit organization A Safe Haven Foundation was awarded a $700,000 grant from the IHCDA that will support the new construction of single-family homes in the West Calumet neighborhood. 

    • (photo courtesy Joseph Pete/The Times of Northwest Indiana)

      ArcelorMittal to Idle Furnace at Indiana Harbor West

      ArcelorMittal plans to idle a blast furnace at its Indiana Harbor West in East Chicago. A spokesperson tells our partners at The Times of Northwest Indiana employees will be reassigned and there will be no layoffs as a result of the move. 

    • A New Way of Thinking for Drug Addiction Recovery

      The long war against drug addiction continues to rage, with the opioid crisis representing the latest front of the battle. As with any long fight, our strategy must change as the forces of death and destruction find new ways to attack those most vulnerable. According to the Centers for Disease Control and Prevention, 68% of the 70,200 drug overdose deaths in 2017 involved an opioid – six times higher than in 1999.

    • Graduates from the 1st cohort for manufacturing at Branchville Correctional Facility (photo ctsy: Dept of Corrections)

      Manufacturing Skills Training for Inmates

      The Indiana Department of Correction is trying to help fill voids in the state’s manufacturing workforce by preparing and training low-risk inmates before they are released. Branchville Correctional Facility in downstate Perry County just graduated its first cohort of the Catapult Training Program, following a four-week course in basic manufacturing skills. The facility is classified as a Level II Low Medium Security Correctional Facility. In an interview with...

    • Calumet Specialty Sells Texas Refinery

      Indianapolis-based Calumet Specialty Products Partners (Nasdaq: CLMT) has closed on the sale of its San Antonio,Texas refinery, crude oil terminal and pipeline to Starlight Relativity Acquisition Co. LLC. Starlight agreed to pay $63 million in cash for the plant, property and equipment.